Acute gram-negative urosepsis mimicking an acute hemolytic transfusion reaction

Transfusion

Volumn 36, Issue 5, 1996, Pages 460-462

  Friedman, H D ^a,b   Noonan, M ^a,c  

^a SYRACUSE VA MEDICAL CENTER   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CLONIDINE; COTRIMOXAZOLE; INSULIN; VANCOMYCIN;

ADULT; ARTICLE; BLOOD TRANSFUSION REACTION; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ESCHERICHIA COLI; HEMATURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; PANCYTOPENIA; SEPSIS; SYMPTOMATOLOGY; URINARY TRACT INFECTION;

EID: 0029886342     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36596282592.x     Document Type: Article

References (16)

1. Beauregard P, Blajchman MA. Hemolytic and pseudo-hemolytic transfusion reactions: an overview of the hemolytic transfusion reactions and the clinical conditions that mimic them. Transfus Med Rev 1994;8:184-99.
2. Walker RH, ed. Technical manual. 11th ed. Bethesda: American Association of Blood Banks, 1993.
3. Capon SM, Goldfinger D. Acute hemolytic transfusion reaction, a paradigm of the systemic inflammatory response: new insights into pathophysiology and treatment. Transfusion 1995;35:513-20.
4. Davenport RD. The role of cytokines in hemolytic transfusion reactions. Immunol Invest 1995;24:319-31.
5. Linden JV, Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion 1992;32:601-6.
6. Linden JV, Kaplan HS. Transfusion errors: causes and effects. Transfus Med Rev 1994;8:169-83.
7. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990;30:583-90.
8. Hazinski MF, Iberti TJ, MacIntyre NR, et al. Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis. Am J Crit Care 1993;2:224-35.
9. Talan DA. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers. Ann Emerg Med 1993;22:1871-90.
10. Dudrick PS, Souba WW. Cytokines, sepsis, and the surgeon: a perspective. Surg Annu 1994;26:1-26.
11. Natanson C, Hoffman WD, Suffredini AF, et al. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994;120:771-83.
12. Goldman M, Blajchman MA. Blood product-associated bacterial sepsis. Transfus Med Rev 1991;5:73-83.
13. Sazama K. Bacteria in blood for transfusion. A review. Arch Pathol Lab Med 1994;118:350-65.
14. Morduchowicz G, Pitlik SD, Huminer D, et al. Transfusion reactions due to bacterial contamination of blood and blood products. Rev Infect Dis 1991;13:307-14.
15. Wright DC, Selss IF, Vinton KJ, Pierce RN. Fatal Yersinia enterocolitica sepsis after blood transfusion. Arch Pathol Lab Med 1985;109:1040-2.
16. Morrow JF, Braine HG, KicklerTS, et al. Septic reactions to platelet transfusions. A persistent problem. JAMA 1991;266:555-8.